Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD
- 15 March 2017
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 49 (3) , 1601298
Abstract
Increased levels of growth differentiation factor-15 (GDF15) are associated with cachexia, cardiovascular disease and all-cause mortality. The role of GDF15 in chronic obstructive pulmonary disease (COPD) is unknown.The study included 413 patients with COPD from the Bergen COPD Cohort Study. All patients had a forced expiratory volume in 1 s (FEV1) 1to forced vital capacity (FVC) ratio 1/FVC were evaluated with regression models.Median plasma GDF15 was 0.86 ng·mL−1(interquartile range 0.64–1.12 ng·mL−1). The distribution was not normal and GDF15 was analysed as a categorical variable. High levels of GDF15 were associated with a higher exacerbation rate (incidence rate ratio 1.39, 95% CI 1.1–1.74, p=0.006, adjusted values). Furthermore, high levels of GDF15 were associated with higher mortality (hazard ratio 2.07, 95% CI 1.4–3.1, p1(4.29%versus3.25%) and FVC (2.63%versus1.44%) in comparison to low levels (p1and FVC.Keywords
This publication has 39 references indexed in Scilit:
- Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2016
- Global burden of COPDRespirology, 2015
- Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgeryInternational Journal of Cardiology, 2015
- Growth Differentiation Factor 15 in Heart Failure: An UpdateCurrent Heart Failure Reports, 2012
- The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolismGrowth Factors, 2011
- Addressing the Complexity of Chronic Obstructive Pulmonary Disease: From Phenotypes and Biomarkers to Scale-Free Networks, Systems Biology, and P4 MedicineAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Growth differentiation factor-15 as a prognostic biomarker in ovarian cancerGynecologic Oncology, 2010
- Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissuesCell and tissue research, 1999
- MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activationJournal of Leukocyte Biology, 1999
- MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamilyProceedings of the National Academy of Sciences, 1997